A long-acting HIV drug arrives in Zimbabwe for some at highest risk

Zimbabwe rolls out long-acting HIV drug, among first countries to do so

Zimbabwe, where HIV has led to tens of thousands of deaths over the past two decades, is one of the first countries to roll out lenacapavir, a long-acting drug that authorities hope will slow new infections.

'Turning point': A long-acting HIV drug arrives in Zimbabwe for some at highest risk

Zimbabwe, where HIV has led to thousands of deaths over the past two decades, is one of the first countries to roll out lenacapavir, a long-acting drug that aut

Zimbabwe roll-out of long-acting HIV prevention drug gets underway

With clinical studies demonstrating near-total protection, lenacapavir has been described by some health officials as a turning point for high-risk groups.

Zimbabwe is one of the first to roll out new and long-acting HIV drug

HARARE, Zimbabwe — Young women, mothers holding babies and some men lined up in a dusty field on the outskirts of Zimbabwe’s capital, Harare. They...

A long-acting HIV drug arrives in Zimbabwe for some at highest risk

Zimbabwe is one of the world's first countries to roll out lenacapavir, a long-acting HIV prevention drug that is administered only twice a year.

Zimbabwe rolls out new long-acting HIV prevention drug

Zimbabwe has begun administering a groundbreaking long-acting injectable drug designed to prevent HIV infection, marking a significant step forward in the country’s ongoing fight against the epidemic.